Voit & Company’s Asensus Surgical, Inc. ASXC Stock Holding History

Voit & Company’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-769	Closed	-$6K	–	76
2019 Q3	$6K	Hold	769	–	–	0.01%	67
2019 Q2	$14K	Hold	769	–	–	0.01%	66
2019 Q1	$24K	Hold	769	–	–	0.03%	72
2018 Q4	$23K	Buy	+769	New	+$34.9K	0.03%	66

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voit & Company's ASXC Position: Q4 2019 in Review

Voit & Company sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 769 shares — an estimated $6K sold.

Voit & Company first reported a position in ASXC in Q4 2018 and held it in 4 quarters. The position peaked at $24K in Q1 2019. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

Voit & Company reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
Voit & Company sold 769 Asensus Surgical, Inc. shares in Q4 2019, an estimated $6K.
Voit & Company first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 4 quarters.
Voit & Company's Asensus Surgical, Inc. position peaked at $24K in Q1 2019.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Voit & Company's 13F filing for Q4 2019, filed 31 Jan 2020.